Skip to main content

Risk factors for presentation with thick primary melanoma include older age, male sex, smoking and may include occupation in certain industries

  • Chapter
  • 56 Accesses

Part of the book series: Developments in Oncology ((DION,volume 73))

Abstract

Malignant melanoma is one of the few human cancers which continues to show an increasing incidence in Australia and other countries [1,2,3,4]. In Australia overall the incidence is now about 25 per 100,000 and in the Newcastle and Northern Coastal Regions of New South Wales 50 per 100,000 of the population [5]. Similar increases in incidence have been documented in other countries with a predominantly Caucasian population [3,6]. The seriousness of this increase is due to the propensity of melanoma to metastasize from its primary site to viscera resulting in death of the patient. Current death rates in Australia are 4.8 and 2.4 per 100,000 men and women respectively or about 800 per annum in Australia [1,3,4].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Giles G, Dwyer T, Coates M, et al. Trends in skin cancer in Australia: an overview of the available data. Trans Menzies Found 1989;15:143–7.

    Google Scholar 

  2. Giles G, Armstrong BK, Smith LR. Cancer in Australia 1982. Canberra: Australasian Association of Cancer Registries and Australian Institute of Health, 1987. National Cancer Statistics Clearing House Scientific Publication No. 1. 1987:34–35.

    Google Scholar 

  3. Grin-Jorgensen CM, Rigel DS, Friedman RJ. The Worldwide incidence of malignant melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. 2nd Edition. Philadelphia: Lippincott, 1992:27–39.

    Google Scholar 

  4. Jones ME, Shugg D, Dwyer T, et al. Interstate differences in incidence and mortality from melanoma. A re-examination of the latitudinal gradient. Med J Aust 1982; 157:373–8.

    Google Scholar 

  5. McCredie M, Coates M, Chu S, Taylor R. Trends in cancer incidence by region in NSW 1972–1990. NSW Cancer Registry, Cancer Epidemiology Research Unit, NSW State Cancer Council, 1992.

    Google Scholar 

  6. Elwood JM, Swerdlow AJ, Cox B. Trends in incidence and mortality from cutaneous melanoma in England and Wales. Trans Menzies Found 1989;15: 131–5.

    Google Scholar 

  7. Breslow A. Tumor thickness, level of invasion and node dissection in stage 1 cutaneous melanoma. Ann Surg 1975; 182:5 72–8.

    Article  Google Scholar 

  8. Balch CM, Soong SJ, Shaw HM, et al. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton AN, Milton GW, Sober AJ, Soong SJ, eds. Cutaneous Melanoma. Philadelphia: Lippincott, 1992:165–87.

    Google Scholar 

  9. McCarthy WH, Shaw HM. Trends in the epidemiology, diagnosis and management of melanoma. Cancer Forum 1990;14:6–10.

    Google Scholar 

  10. Little JH, Holt J, Davis N. Changing epidemiology of malignant melanoma in Queensland. Med J Aust 1980; 1:66–9.

    PubMed  CAS  Google Scholar 

  11. Ring IT, Walker SM, Firman D, et al. Melanoma in Queensland. Trans Menzies Found 1989; 15:157–63.

    Google Scholar 

  12. McLeod GR. Control of melanoma in high-risk populations. In: Elwood JM, ed. Melanoma and Naevi. Pigment Cell. Vol. 9. Basel: Karger, 1988:133.

    Google Scholar 

  13. Doherty VR, MacKie RM. Experience of a public education programme on early detection of cutaneous malignant melanoma. Br Med J 1988;297:388–91.

    Article  CAS  Google Scholar 

  14. Arundell FD. Screening for melanoma and skin cancer (letter). JAMA 1986;255:2443–4.

    Article  PubMed  CAS  Google Scholar 

  15. Berwick DM. Screening in health fairs. JAMA 1985;254:1492–8.

    Article  PubMed  CAS  Google Scholar 

  16. Koh HK, Lew RA, Prout MN. Screening for melanoma/skin cancer: theoretic and practical considerations. J Am Acad Dermatol 1989;20:159–72.

    Article  PubMed  CAS  Google Scholar 

  17. Swerdlow AJ, English J, MacKie RM, et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986;292:1555–9.

    Article  CAS  Google Scholar 

  18. Greene MH, Clark WH, Tucker MA, et al. Acquired precursors of cutaneous malignant melanoma. The familial dysplastic nevus syndrome. N Engl J Med 1985;312:91–7.

    CAS  Google Scholar 

  19. Holman CDJ, Armstrong BK, Heenan PJ, et al. The causes of malignant melanoma: results from the West Australian Lions Melanoma Research Project. Recent Results Cancer Res 1986; 102:18–37.

    Article  PubMed  CAS  Google Scholar 

  20. English DR, Armstrong BK. Identifying people at high risk of cutaneous malignant melanoma: results from a case-control study in Western Australia. Br Med J 1988;296:1285–8.

    Article  CAS  Google Scholar 

  21. Hiatt RA, Fireman B. The possible effect of increased surveillance on the incidence of malignant melanoma. Prev Med 1986;15:652–60.

    Article  PubMed  CAS  Google Scholar 

  22. Schneider JS, Sagebiel RW, Moore DH, Lawton GM. Melanoma surveillance and earlier diagnosis (letter) 1987;1:1435.

    CAS  Google Scholar 

  23. Hersey P, Prendergast D, Edwards A. Effects of cigarette smoking on the immune system. Med J Aust 1983;2:425–9.

    PubMed  CAS  Google Scholar 

  24. Shaw HM, McCarthy WH, Milton GW. Melanoma: Differing clinical patterns in older men and women. Geriatric Medicine Today 1985;4:31–43.

    Google Scholar 

  25. Loggie B, Ronan SG, Bean J, Das Gupta TK. Invasive cutaneous melanoma in elderly patients. Arch Dermatol 1991;127:1188–93.

    Article  PubMed  CAS  Google Scholar 

  26. Cohen HJ, Cox E, Manton K, Woodbury M. Malignant melanoma in the elderly. J Clin Oncol 1987;5:100–6.

    PubMed  CAS  Google Scholar 

  27. Cassileth BR, Clark WH, Heiberger RM, et al. Relationship between patients’ early recognition of melanoma and depth of invasion. Cancer 1982;49:198–200.

    Article  PubMed  CAS  Google Scholar 

  28. Temoshok L, D’Clemente RJ, Sweet DM, et al. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma. Cancer 1984;54:3048–53.

    Article  PubMed  CAS  Google Scholar 

  29. Andersen WK, Silvers DN. ‘Melanoma’. It can’t be melanoma! JAMA 1991;266:3463–5.

    CAS  Google Scholar 

  30. Shaw HM, McGovern VJ, Milton GW, Farago GA. Cutaneous malignant melanoma: occupation and prognosis. Med J Aust 1981;l:37–8.

    Google Scholar 

  31. Girgis A, Campbell E, Redman S, Sanson-Fisher RW. Screening for melanoma: a community survey of the prevalence and predictors. Med J Aust 1991;154:338–43.

    PubMed  CAS  Google Scholar 

  32. Brown R, Pang G, Husbands AJ, King MG. Suppression of immune responses to influenza virus in the respiratory tract following sleep deprivation. Regional Immunology 1989;2:321–5.

    PubMed  CAS  Google Scholar 

  33. Shaw HM, Milton GW, McCarthy WH, Farago GA, Dilworth P. Effect of smoking on the recurrence of malignant melanoma. Med J Aust 1979; 1:208–9.

    PubMed  CAS  Google Scholar 

  34. Shaw HM, Milton GW. Smoking and the development of métastases from malignant melanoma. Int J Cancer 1981;28:153–6.

    Article  PubMed  CAS  Google Scholar 

  35. Koh HK, Sober AJ, Day CL Jr., et al. Cigarette smoking and malignant melanoma. Cancer 1984;53:2570–3.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1994 Springer Science+Business Media New York

About this chapter

Cite this chapter

Hersey, P., Strong, T., Grant, D., Marish, Z. (1994). Risk factors for presentation with thick primary melanoma include older age, male sex, smoking and may include occupation in certain industries. In: Gallagher, R.P., Elwood, J.M. (eds) Epidemiological Aspects of Cutaneous Malignant Melanoma. Developments in Oncology, vol 73. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2626-1_17

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-2626-1_17

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6126-8

  • Online ISBN: 978-1-4615-2626-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics